Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation

Published:2017-02-14 Issue:4 Volume:31 Page:1020-1022
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kobayashi S,Kobayashi A,Osawa Y,Nagao S,Takano K,Okada Y,Tachi N,Teramoto M,Kawamura T,Horiuchi T,Kato S,Maekawa T,Yamamura T,Watanabe J,Harada Y,Harada H,Sato K,Kimura F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu201744.pdf

Reference9 articles.

1. Berger G, van den Berg E, Sikkema-Raddatz B, Abbott KM, Sinke RJ, Bungener LB et al. Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation. Leukemia 2017; 31: 520–522.

2. Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 2015; 27: 658–670.

3. Wiseman DH . Donor cell leukemia: a review. Biol Blood Marrow Transplant 2011; 17: 771–789.

4. Hahn CN, Ross DM, Feng J, Beligaswatte A, Hiwase DK, Parker WT et al. A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone. Leukemia 2015; 29: 2101–2104.

5. Hirsch P, Mamez AC, Belhocine R, Lapusan S, Tang R, Suner L et al. Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation. Leukemia 2016; 30: 1756–1759.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood;2024-09-03

2. Multifunctional role of DEAD-box helicase 41 in innate immunity, hematopoiesis and disease;Frontiers in Immunology;2024-08-09

3. How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms;HemaSphere;2024-08

4. The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies;Genes;2024-07-01

5. Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia;JCO Precision Oncology;2024-06